Britannia Life Sciences Past Earnings Performance
Past criteria checks 2/6
Britannia Life Sciences has been growing earnings at an average annual rate of 21.3%, while the Professional Services industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 24.9% per year. Britannia Life Sciences's return on equity is 15.9%, and it has net margins of 22.8%.
Key information
21.3%
Earnings growth rate
49.7%
EPS growth rate
| Professional Services Industry Growth | 14.5% |
| Revenue growth rate | 24.9% |
| Return on equity | 15.9% |
| Net Margin | 22.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Britannia Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 7 | 2 | 4 | 0 |
| 30 Sep 23 | 7 | 1 | 4 | 0 |
| 30 Jun 23 | 7 | 2 | 3 | 0 |
| 31 Mar 23 | 6 | 5 | 4 | 0 |
| 31 Dec 22 | 7 | -1 | 4 | 0 |
| 30 Sep 22 | 7 | -11 | 4 | 0 |
| 30 Jun 22 | 7 | -13 | 4 | 0 |
| 31 Mar 22 | 7 | -15 | 4 | 0 |
| 31 Dec 21 | 7 | -10 | 3 | 0 |
| 30 Sep 21 | 5 | 0 | 2 | 0 |
| 30 Jun 21 | 3 | 0 | 1 | 0 |
| 31 Mar 21 | 1 | 0 | 1 | 0 |
Quality Earnings: L020 has a large one-off gain of CA$861.2K impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: L020 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: L020 has become profitable over the past 5 years, growing earnings by 21.3% per year.
Accelerating Growth: L020 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: L020 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Professional Services industry (-6.4%).
Return on Equity
High ROE: L020's Return on Equity (15.9%) is considered low.